GlassScriptPhysician profile
Tu A Dao
NPI 1881875383
$41,306.57
in general payments reported to CMS, 2019-2025
42 companies · $1,951 in 2025
The $1,951 reported for 2025 was more than what 83% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $339 · 2021: $953 · 2022: $2,403 · 2023: $1,803 · 2024: $1,349 · 2025: $1,951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,553 · Food and Beverage: $2,550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,553.08 |
| Food and Beverage | $2,549.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fuse Medical, INC. | $25,240.32 | 2019 | |
| Cpm Medical Consultants, LLC | $4,500.00 | 2019 | |
| Treace Medical Concepts, INC. | $3,944.26 | 2019-2025 | |
| Pylant Medical | $2,102.03 | 2019-2025 | |
| Stryker Corporation | $1,361.44 | 2020-2025 | Augment Injectable, Na, Citrefix |
| Paragon 28, INC. | $683.64 | 2019 | |
| International Life Sciences | $441.20 | 2024 | Flexband |
| Smith+Nephew, INC. | $322.10 | 2019-2025 | Hat-Trick, Uni Cp, Renasys Go V2 Home |
| Integra Lifesciences Corporation | $303.80 | 2019-2021 | |
| Amgen INC. | $300.09 | 2024-2025 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $290.70 | 2021-2025 | Nuzyra |
| Arthrex, INC. | $288.20 | 2025 | |
| Biotissue Holdings INC. | $275.42 | 2022-2023 | |
| Convatec INC. | $130.98 | 2025 | |
| Gilead Sciences, INC. | $121.38 | 2024 | Vemlidy |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $115.08 | 2023-2024 | Senza |
| Horizon Therapeutics Plc | $105.21 | 2019-2023 | Krystexxa |
| Tactile Systems Technology INC | $97.70 | 2020-2023 | Flexitouch Plus, Entre Plus |
| Biowound Solutions, INC. | $86.20 | 2025 | Bio-Connekt |
| Depuy Synthes Sales INC. | $76.90 | 2024-2025 | Va-Lcp |
| Organogenesis INC. | $68.63 | 2023 | Puraply |
| Melinta Therapeutics, LLC | $68.27 | 2019 | |
| Orthofix Medical, INC. | $52.73 | 2020-2025 | Physio-Stim |
| Wright Medical Technology, INC. | $32.79 | 2019 | |
| Globus Medical, INC. | $24.68 | 2025 | Senza |
| Kci USA, INC. | $23.30 | 2019 | |
| Merck Sharp & Dohme LLC | $22.89 | 2019 | |
| Sanara Medtech INC. | $21.22 | 2022 | |
| Fidia Pharma USA INC. | $19.47 | 2025 | |
| Normatec Industries, LP | $18.51 | 2019 | |
| Orpyx Medical Technologies US INC. | $18.48 | 2023 | Orpyx Si |
| Hartmann USA, INC. | $17.67 | 2025 | Zetuvit Plus 10x10 P10 |
| Acell, INC. | $16.41 | 2019 | |
| Nabriva Therapeutics, Plc | $15.84 | 2020 | |
| Cashflow Solutions, LLC | $15.62 | 2024 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Checkpoint Surgical, INC | $14.47 | 2021 | |
| Kerecis Limited | $12.11 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Trice Medical, INC. | $12.07 | 2020 | |
| Arthrosurface Incorporated | $12.04 | 2019 | |
| Advanced Oxygen Therapy INC. | $11.90 | 2020 | |
| Molnlycke Health Care US, LLC | $10.43 | 2021 | |
| Aroa Biosurgery Incorporated | $10.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tu Dao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.